Efficacy and Safety of Topical Mechanistic Target of Rapamycin Inhibitors for Facial Angiofibromas in Patients with Tuberous Sclerosis Complex: A Systematic Review and Network Meta-Analysis

Previous studies have suggested that the topical mechanistic target of rapamycin (mTOR) inhibitors may be effective in treating facial angiofibromas in patients with tuberous sclerosis complex (TSC). Various concentrations of topical sirolimus for TSC have been tested, but their comparative efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yu-Ting, Yu, Chia-Ling, Tu, Yu-Kang, Chi, Ching-Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025300/
https://www.ncbi.nlm.nih.gov/pubmed/35453576
http://dx.doi.org/10.3390/biomedicines10040826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025300/
https://www.ncbi.nlm.nih.gov/pubmed/35453576
http://dx.doi.org/10.3390/biomedicines10040826

Ejemplares similares